Tagged: VRX

Netflix, Inc. (NASDAQ:NFLX) 0

Morning Beat: Netflix, Inc. (NFLX), Microsoft Corporation (MSFT), and Valeant Pharmaceuticals Intl Inc (VRX)

Netflix, Inc.(NASDAQ:NFLX) shares are down by 8.67% in pre-market after CEO, Reed Hastings, raised concerns about the company’s growth prospects on the international front. The Streaming giant says it expects 2 million new subscribers...

Valeant VRX 0

Road Ahead For Valeant Pharmaceuticals Intl Inc (VRX)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been in the thick of news in the last six-month period for all the wrong reasons. As a result, the stock has been witnessing a downward trend with...

Valeant VRX 0

Morning Beat: Valeant Pharmaceuticals Intl Inc (VRX), International Business Machines Corp. (IBM), and BP plc (ADR) (BP)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares continued to tank in the market after the company said it will restate its 2014 and 2015 financial results. The company says it will restate the results having...

Bill Ackman 0

Key Takeaways From Pershing Square Annual Letter

One of the takeaways from the Perishing Square Capital Management L.P.’s annual letter to its investors was that it regretted the lost opportunity in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Its gross return was down...

Valeant VRX 0

Healthcare Pulse: Valeant Pharmaceuticals Intl Inc (VRX), Mylan NV (MYL), and Pfizer Inc. (PFE)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Turing were yet again the subjects of immense criticism from senators over their unfair drug pricing practices. A special Senate hearing denounced the practices terming them irresponsible with...

GlaxoSmithKline plc (ADR) (NYSE:GSK) 0

Weekly Recap 11-16/11-20: GlaxoSmithKline plc (ADR) (GSK), Valeant Pharmaceuticals Intl Inc (VRX), and Microsoft Corporation (MSFT)

GlaxoSmithKline plc (ADR) (NYSE:GSK) is quietly engaged in the process of revolutionizing medicine globally. For this, the company has involved itself in researching on the ways to tap natural systems of the body to...